Kaspi kz JSC Sued for Securities Law Violations: Learn About Your Rights and Potential Legal Options Before February 18, 2025 – Consult The Gross Law Firm

Important Notice for Shareholders of Joint Stock Company Kaspi.kz (KSPI) NEW YORK, Feb. 03, 2025 – The Gross Law Firm, a leading securities law firm, issues the following notice to all shareholders of Joint Stock Company Kaspi.kz (KSPI) regarding ongoing investigations into potential securities laws violations. Background Joint Stock Company Kaspi.kz, also known as Kaspi.kz…

Read More

USCF Summerhaven Dynamic Commodity Strategy: Kicking Butt and Collecting Accolades – A Growth Story

USCF Investments: A New Milestone of $500 Million in Assets Under Management WALNUT CREEK, Calif., Feb. 3, 2025 – In an exciting development for the exchange-traded fund (ETF) industry, USCF Investments, a pioneering force in ETF innovation, has announced the achievement of a significant milestone. With assets under management (AUM) surpassing the $500 million mark,…

Read More

Levi and Korsinsky: Your Stock Alert for Bioage Labs, Inc. (BIOA) – A Friendly Reminder from Your AI Buddy

BioAge Labs, Inc. (BIOA) Investors: Understanding Your Options After a Loss If you’ve recently experienced a loss on your investment in BioAge Labs, Inc. (NASDAQ:BIOA), you’re not alone. It’s a tough pill to swallow, but you’re not without recourse. In this blog post, we’ll discuss your potential options under federal securities laws and what it…

Read More

Class Action Alert: Applied Therapeutics, Inc. – Levi & Korsinsky Law Firm Encourages Shareholders to Consider Their Rights

Learning About Potential Recovery for Losses in Applied Therapeutics, Inc. (APLT) Investments If you have recently experienced a financial loss following an investment in Applied Therapeutics, Inc. (APLT) and are seeking information regarding potential recovery under federal securities laws, this article aims to provide you with the necessary details. Background on Applied Therapeutics, Inc. (APLT)…

Read More

Cargo Therapeutics, Inc. (CRGX): Shareholders Urged to Review Potential Impact on Their Investments

Investigation Launched Against CARGO Therapeutics, Inc. Following Discontinuation of Clinical Trial On January 29, 2025, CARGO Therapeutics, Inc. (NASDAQ: CRGX) announced that it had decided to discontinue the FIRCE-1 Phase 2 clinical study of its lead product candidate, firi-cel, for patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19…

Read More

Fingerprint Cards Invites You: A Warm Invitation to Discover Innovations in Biometric Technology at Our Digital Presentation on February 5, 2025

Fingerprints™: Unveiling the Future of Biometric Technology On February 5, 2025, at 2:00 PM CET, Fingerprint Cards AB (Fingerprints™) will host a digital company presentation. This event is an exciting opportunity for investors, industry professionals, and tech enthusiasts to gain a deeper understanding of the latest advancements in biometric technology from Fingerprints’ leadership team. CEO…

Read More